Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2019-08-12 2019-08-12
Drug Identification Number 02394812 02394812
Brand name CANDESARTAN HCT CANDESARTAN HCT
Common or Proper name CANDESARTAN HCT CANDESARTAN HCT
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 12.5MG 16MG 12.5MG 16MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-09-16 2019-09-16
Actual start date
Estimated end date Unknown Unknown
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments